Research ArticleClinical Studies
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA
Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
CHIARA CICCARESE
1Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
2Università Cattolica del Sacro Cuore, Rome, Italy;
ROBERTO IACOVELLI
1Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
SEBASTIANO BUTI
3Medical Oncology Unit, University Hospital of Parma, Parma, Italy;
FRANCESCA PRIMI
4Department of Medical Oncology, Belcolle Hospital of Viterbo, Viterbo, Italy;
SERENA ASTORE
2Università Cattolica del Sacro Cuore, Rome, Italy;
FRANCESCO MASSARI
5Department of Medical Oncology, Sant’Orsola-Malpighi Hospital, Bologna, Italy;
MIRIAM GRAZIA FERRARA
2Università Cattolica del Sacro Cuore, Rome, Italy;
GIUSEPPE PALERMO
6Department of Urology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
NAZARIO FOSCHI
6Department of Urology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
VALERIO IACOVELLI
7Department of Urology, San Carlo di Nancy Hospital, Rome, Italy
ERNESTO ROSSI
1Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
GIOVANNI SCHINZARI
1Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
2Università Cattolica del Sacro Cuore, Rome, Italy;
PIERLUIGI BOVE
7Department of Urology, San Carlo di Nancy Hospital, Rome, Italy
PIERFRANCESCO BASSI
5Department of Medical Oncology, Sant’Orsola-Malpighi Hospital, Bologna, Italy;
EMILIO BRIA
1Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
2Università Cattolica del Sacro Cuore, Rome, Italy;
GIAMPAOLO TORTORA
1Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
2Università Cattolica del Sacro Cuore, Rome, Italy;
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA, GIAMPAOLO TORTORA
Anticancer Research Mar 2022, 42 (3) 1487-1493; DOI: 10.21873/anticanres.15620
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA, GIAMPAOLO TORTORA
Anticancer Research Mar 2022, 42 (3) 1487-1493; DOI: 10.21873/anticanres.15620
Jump to section
Related Articles
- No related articles found.